SPINEMarketGroup

LONDON--(BUSINESS WIRE)--Marathon Asset Management (“Marathon”), a leading global credit manager with more than $24 billion of assets under management, is pleased to announce the closing of a junior capital financing to EXALTA Group (“EXALTA” or the “Company”), a portfolio company of Montagu. Marathon led the financing that supported the formation … [Read More...] about Marathon Asset Management Provides Junior Capital Financing to EXALTA Group

DIAM™ Spinal Stabilization System is the first posterior motion-preserving device approved in the U.S. for the treatment of moderate to severe primary low back pain A breakthrough treatment addressing both undertreatment and overtreatment in the current care pathway, with robust evidence demonstrating superiority over non-operative care DIAM™ Spinal Stabilization System has demonstrated … [Read More...] about Companion Spine Announces FDA Premarket Approval (“PMA”) of the DIAM™ Spinal Stabilization System for the Treatment of Degenerative Disc Disease (“DDD”)

Laminoplasty became popular in the 1980s and was developed to treat multilevel pathology of the cervical spine. Initially, its indications were focused on cases of ossification of the posterior longitudinal ligament and cervical spondylotic myelopathy. Since then, its application has been expanded to other indications that require expansion of the cervical canal.Laminoplasty has shown be as … [Read More...] about (UPDATED 2025): +30 Laminoplasty Plates to Know..!

Today, everybody say that AI and robotics will change everything. However, this type of prediction is not new. The world and our industry has heard similar promises before. More than ten years ago, when 3D printing started, the narrative was very similar: manufacturing would become fully additive, implants would be patient-specific, and hospitals would print their own medical devices. Some … [Read More...] about The Spine Industry and Additive Manufacturing: Still Waiting for the Future?

In the fast-moving spine device industry, reliable technical documentation is essential — which is why our Brochures section has become a trusted industry reference. Whether you are a surgeon, sales representative, product manager, engineer, or researcher, this section offers a centralized library of spine product brochures and surgical techniques that can save you time and deliver valuable … [Read More...] about How the Brochure Section of SPINEMarketGroup Can Help You in Your Daily Work?

LOS ANGELES--(BUSINESS WIRE)--Ruthless Spine today announced that Gad Medical Ltd. has received regulatory approval to immediately start sales in Israel of Ruthless Spine’s RJB interoperative angle measurement instrument. This development follows their agreement on distribution rights to the RJB, enabling hospitals and surgical centers to access a U.S.-engineered implant platform designed for … [Read More...] about Gad Medical Ltd. Receives Regulatory Approval to Start Sales of Ruthless Spine’s RJB Interoperative Angle Measurement Instrument in Israel, Marking Significant Expansion Following NASS Momentum

The spinal implants market in Brazil is a significant niche within the medical device industry, showing steady growth in recent years. According to 2024 reports, the spinal implants and devices market in Brazil generated approximately USD 400-450 million. It is projected to reach USD 850 million by 2033, with a compound annual growth rate (CAGR) of 7.5% between 2025–2033.Within the Latin American … [Read More...] about Inside Brazil’s $450M Spinal Implant Market: Key Local Players and Regulations

New policy expands patient access to Intracept Procedure for chronic vertebrogenic back pain, covering 26 million lives What’s New: Boston Scientific today announced that Health Care Service Corporation (HCSC), one of the largest commercial health insurers in the U.S., now covers the Intracept™ Procedure for eligible patients with chronic vertebrogenic low back pain. The policy went into … [Read More...] about Boston Scientific announces positive coverage policy for the Intracept™ Procedure by Health Care Service Corporation

PLEASANTON, Calif., Dec. 9, 2025 /PRNewswire/ -- Providence Medical Technology, Inc., an innovator in solutions for spinal surgery, announces that its CORUS™ Navigation Access System-GLX ("CORUS-GLX System") is now compatible with Globus Medical's ExcelsiusGPS™ Robotic Navigation Platform for use during spinal fusion surgery. This new compatibility clearance strengthens … [Read More...] about Providence Medical Technology, Inc. Announces Compatibility of CORUS-GLX™ System with Globus Medical’s Excelsius™ Navigation System for Posterior Lumbar Fusion

Wervicq, France - December 10. 2025--Cousin Surgery, a major player in implantable medical devices, is expanding its range of spinal surgery products with the acquisition of C Disc, the first reverse cervical prosthesis with a double centre of rotation. The innovative design and exclusive biomechanical performance of this implant enables surgeons to preserve and control cervical segment mobility … [Read More...] about With the C Disc cervical prosthesis,Cousin Surgery strengthens its range of implants dedicated to preserving mobility

Strasbourg, France – December 8, 2025 – SC Medica today announced that its FFX® Facet FiXation System has received U.S. Food and Drug Administration (FDA) clearance for cervical use, marking a significant expansion of its clinical indications in the United States. Following the recent FDA authorization of FFX® for standalone lumbar facet arthrodesis, this new … [Read More...] about FFX® Receives FDA Clearance for Cervical Facet Arthrodesis, Expanding its U.S. indications

Today I read an article titled “Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think ‘Yes’, and I found it interesting enough to comment on. The article explains why Globus Medical may be an attractive option for growth-oriented investors, focusing on earnings growth, strong cash flow, and positive revisions to earnings estimates. While it presents a convincing case, it is still worth … [Read More...] about Commentary on “Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think ‘Yes’”